INS and type 2 diabetes mellitus: Mechanistically, tirzepatide exerts multiple beneficial effects, including stimulation of insulin secretion, inhibition of gastric emptying, appetite suppression, and improvement of insulin sensitivity, rendering it theoretically advantageous for treating patients with coexisting T2DM and AS [12].